JinSong Li1, GuanBo Zhang1, Gang Li1

  • 1Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China.

Discover oncology
|February 5, 2025
PubMed
概括

免疫疗法对肝细胞癌 (HCC) 有希望,但面临阻力. 纳米粒子提供了一种新的策略,通过向HCC中的瘤微环境 (TIME) 来增强免疫疗法.